Investment
Features
FeesSafety
Academy
More
Pluang+

Nextech3D.AI CEO to receive shares instead of unpaid salary, boosting company cash flow and aligning interests.

Company Fundamentals
17 Sep 2026
Proactive Investors
View Source
Bullish
Nextech3D.AI CEO to receive shares instead of unpaid salary, boosting company cash flow and aligning interests.

Nextech3D.AI will issue 7.42 million shares to CEO Evan Gappelberg to settle $742,088 in unpaid salary. This share issuance reduces company liabilities and preserves cash for growth initiatives like sales expansion and product development. The CEO's choice to accept shares aligns his interests with shareholders, and he remains a major investor in the company. Nextech3D.AI focuses on AI-driven event technology and immersive digital experiences, with recent stock gains reflecting investor optimism.

Nextech3D.ai CEO's share issuance news comes alongside a strong Technology sector performance on Pluang. For readers following this sector, here is Pluang's market snapshot as of Sep 17, 2026 23:02 WIB: Out of 150 priced US tech stocks, 119 rose and 30 fell today. Notably, SMCI gained 9.12% to USD 40.21 with a typical hold time of 18 days and a buy order activity of 57%, while RGTI increased 8.59% to USD 16.06 with a 30-day hold and 87% buy orders. QBTS also rose 8.48% to USD 17.65 but saw 97% sell orders despite a 29-day hold time.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App